Pharma firm licence revoked over Kota post-partum deaths; WHO seeks report
GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·
Why in news
The WHO requested a report from the Indian government regarding five post-partum deaths in Kota, Rajasthan, linked to spurious oxytocin injections manufactured by Jackson Laboratories.
Background
The Central Drugs Standard Control Organisation (CDSCO) and state regulators conducted joint inspections leading to the cancellation of Jackson Laboratories' manufacturing licenses. The Union Health Ministry is currently seeking a detailed fact-finding report from the Rajasthan government.
Facts for Prelims
- BodyCDSCO: Theprimary national regulatory body for cosmetics, pharmaceuticals, and medical devices in India.
- BodyWHO: The United Nations agency responsible for international public health.
- FactThe incident involved five post-partum deaths linked to spurious oxytocin injections in Kota, Rajasthan.
For Mains
Q. Critically analyze the regulatory framework governing the pharmaceutical industry in India and suggest measures to ensure the quality and safety of essential medicines.
Dimensions to cover in your answer
- Regulatory oversight gap: Inadequate real-time monitoring of manufacturing units leads to the circulation of spurious drugs.
- Supply chain vulnerability: Lack of robust tracking mechanisms for high-risk maternal health medications like oxytocin.
- Institutional coordination: Delays in information sharing between state drug regulators and the CDSCO during public health emergencies.
Keywords: Regulatory oversight · Public health safety · Pharmaceutical integrity · Quality assurance · Zero-tolerance policy
More Social Justice notes
- Court refuses stay on Karnataka gig workers act, directs platforms to deposit welfare fee · 4 July 2026
- APSCHE to Train 50,000 Students for AI Jobs Amidst Evolving Market · 3 July 2026
- Maharashtra FDA Slams Milk Adulteration, Issues Strict New Rules · 3 July 2026
- Kerala Court: College Can't Withhold Student's Marksheets Over Fees · 3 July 2026
- Govt brings stem cell, gene therapies under Central licensing ambit · 3 July 2026
- Experts discuss One Health at two-day conference in Chennai · 2 July 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
Report a mistake →Ask for something →thesatyadheesh@gmail.com
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.